Titan Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Titan Biotech has a total shareholder equity of ₹1.2B and total debt of ₹85.6M, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are ₹1.5B and ₹266.6M respectively. Titan Biotech's EBIT is ₹307.2M making its interest coverage ratio 41.2. It has cash and short-term investments of ₹45.6M.
Key information
7.1%
Debt to equity ratio
₹85.65m
Debt
Interest coverage ratio | 41.2x |
Cash | ₹45.64m |
Equity | ₹1.21b |
Total liabilities | ₹266.55m |
Total assets | ₹1.48b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524717's short term assets (₹752.6M) exceed its short term liabilities (₹213.8M).
Long Term Liabilities: 524717's short term assets (₹752.6M) exceed its long term liabilities (₹52.8M).
Debt to Equity History and Analysis
Debt Level: 524717's net debt to equity ratio (3.3%) is considered satisfactory.
Reducing Debt: 524717's debt to equity ratio has reduced from 85.3% to 7.1% over the past 5 years.
Debt Coverage: 524717's debt is well covered by operating cash flow (261.6%).
Interest Coverage: 524717's interest payments on its debt are well covered by EBIT (41.2x coverage).